<?xml version='1.0' encoding='UTF-8'?>
<Organism_Record>
  <Organism_ID>ASD01130000_1</Organism_ID>
  <Organism>Human</Organism>
  <Organism_Latin>Homo sapiens</Organism_Latin>
  <UniProt_ID>P04075</UniProt_ID>
  <Seq_Length>364</Seq_Length>
  <Molecule_Weight>39420</Molecule_Weight>
  <KEGG_ID>hsa:226</KEGG_ID>
  <Orthology_ID>K01623</Orthology_ID>
  <Function_Summary>Plays a key role in glycolysis and gluconeogenesis. In addition, may also function as scaffolding protein (By similarity).</Function_Summary>
  <Catalytic_Mechanism>D-fructose 1,6-bisphosphate = glycerone phosphate + D-glyceraldehyde 3-phosphate.</Catalytic_Mechanism>
  <Pfam_ID>PF00274:Glycolytic</Pfam_ID>
  <Allosteric_Activator_Count>0</Allosteric_Activator_Count>
  <Allosteric_Inhibitor_Count>5</Allosteric_Inhibitor_Count>
  <Allosteric_Regulator_Count>0</Allosteric_Regulator_Count>
  <Alias_List>
      <Alias>Fructose-bisphosphate aldolase A</Alias>
      <Alias>Muscle-type aldolase</Alias>
      <Alias>Fructose-1,6-bisphosphate triosephosphate-lyase</Alias>
      <Alias>Lung cancer antigen NY-LU-1</Alias>
  </Alias_List>
  <Function_List>
    <Funtion>
      <Detail>Catalysis of the reaction: D-fructose 1,6-bisphosphate = glycerone phosphate + D-glyceraldehyde-3-phosphate.</Detail>
      <Keyword>Fructose-bisphosphate aldolase activity</Keyword>
      <Ontology_ID>GO:0004332</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with an identical protein or proteins.</Detail>
      <Keyword>Identical protein binding</Keyword>
      <Ontology_ID>GO:0042802</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the cleavage of C-C, C-O, C-N and other bonds by other means than by hydrolysis or oxidation, or conversely adding a group to a double bond. They differ from other enzymes in that two substrates are involved in one reaction direction, but only one in the other direction. When acting on the single substrate, a molecule is eliminated and this generates either a new double bond or a new ring.</Detail>
      <Keyword>Lyase activity</Keyword>
      <Ontology_ID>GO:0016829</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with the D- or L-enantiomer of fructose, the ketohexose arabino-hex-2-ulose.</Detail>
      <Keyword>Fructose binding</Keyword>
      <Ontology_ID>GO:0070061</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with monomeric or multimeric forms of tubulin, including microtubules.</Detail>
      <Keyword>Tubulin binding</Keyword>
      <Ontology_ID>GO:0015631</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with monomeric or multimeric forms of actin, including actin filaments.</Detail>
      <Keyword>Actin binding</Keyword>
      <Ontology_ID>GO:0003779</Ontology_ID>
    </Funtion>
  </Function_List>
  <Mutation_List>
    <Muntion>
      <Position>207</Position>
      <Original>Glu</Original>
      <Variation>Lys</Variation>
    </Muntion>
    <Muntion>
      <Position>142</Position>
      <Original>Gly</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>82</Position>
      <Original>Glu</Original>
      <Variation>Gln</Variation>
    </Muntion>
    <Muntion>
      <Position>339</Position>
      <Original>Cys</Original>
      <Variation>Tyr</Variation>
    </Muntion>
    <Muntion>
      <Position>347</Position>
      <Original>Gly</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>129</Position>
      <Original>Asp</Original>
      <Variation>Gly</Variation>
    </Muntion>
  </Mutation_List>
  <BioProcess_List>
    <BioProcess>
      <Detail>The chemical reactions and pathways involving fructose 1,6-bisphosphate, also known as FBP. The D enantiomer is a metabolic intermediate in glycolysis and gluconeogenesis.</Detail>
      <Keyword>Fructose 1,6-bisphosphate metabolic process</Keyword>
      <Ontology_ID>GO:0030388</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A series of progressive, overlapping events triggered by exposure of the platelets to subendothelial tissue. These events include shape change, adhesiveness, aggregation, and release reactions. When carried through to completion, these events lead to the formation of a stable hemostatic plug.</Detail>
      <Keyword>Platelet activation</Keyword>
      <Ontology_ID>GO:0030168</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The chemical reactions and pathways resulting in the formation of ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.</Detail>
      <Keyword>ATP biosynthetic process</Keyword>
      <Ontology_ID>GO:0006754</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of cytoskeletal structures comprising actin filaments. Includes processes that control the spatial distribution of actin filaments, such as organizing filaments into meshworks, bundles, or other structures, as by cross-linking.</Detail>
      <Keyword>Actin filament organization</Keyword>
      <Ontology_ID>GO:0007015</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The regulated exocytosis of secretory granules containing preformed mediators such as histamine and serotonin by a platelet.</Detail>
      <Keyword>Platelet degranulation</Keyword>
      <Ontology_ID>GO:0002576</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The cellular homeostatic process that preserves a muscle cell in a stable functional or structural state.</Detail>
      <Keyword>Muscle cell homeostasis</Keyword>
      <Ontology_ID>GO:0046716</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The chemical reactions and pathways resulting in the breakdown of a monosaccharide (generally glucose) into pyruvate, with the concomitant production of a small amount of ATP. Pyruvate may be converted to ethanol, lactate, or other small molecules, or fed into the TCA cycle.</Detail>
      <Keyword>Glycolysis</Keyword>
      <Ontology_ID>GO:0006096</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A process in which force is generated within striated muscle tissue, resulting in the shortening of the muscle. Force generation involves a chemo-mechanical energy conversion step that is carried out by the actin/myosin complex activity, which generates force through ATP hydrolysis. Striated muscle is a type of muscle in which the repeating units (sarcomeres) of the contractile myofibrils are arranged in registry throughout the cell, resulting in transverse or oblique striations observable at the level of the light microscope.</Detail>
      <Keyword>Striated muscle contraction</Keyword>
      <Ontology_ID>GO:0006941</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The formation of a protein homotetramer, a macromolecular structure consisting of four noncovalently associated identical subunits.</Detail>
      <Keyword>Protein homotetramerization</Keyword>
      <Ontology_ID>GO:0051289</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that modulates the surface configuration of a cell.</Detail>
      <Keyword>Regulation of cell shape</Keyword>
      <Ontology_ID>GO:0008360</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The formation of glucose from noncarbohydrate precursors, such as pyruvate, amino acids and glycerol.</Detail>
      <Keyword>Gluconeogenesis</Keyword>
      <Ontology_ID>GO:0006094</Ontology_ID>
    </BioProcess>
  </BioProcess_List>
  <PTM_List>
    <PTM>
      <Position>9</Position>
      <PTM_Type>Phosphothreonine</PTM_Type>
    </PTM>
    <PTM>
      <Position>223</Position>
      <PTM_Type>Phosphotyrosine</PTM_Type>
    </PTM>
    <PTM>
      <Position>5</Position>
      <PTM_Type>Phosphotyrosine</PTM_Type>
    </PTM>
    <PTM>
      <Position>354</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
    <PTM>
      <Position>111</Position>
      <PTM_Type>N6-malonyllysine</PTM_Type>
    </PTM>
    <PTM>
      <Position>42</Position>
      <PTM_Type>N6-acetyllysine</PTM_Type>
    </PTM>
    <PTM>
      <Position>364</Position>
      <PTM_Type>Phosphotyrosine</PTM_Type>
    </PTM>
    <PTM>
      <Position>356</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
    <PTM>
      <Position>36</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
    <PTM>
      <Position>330</Position>
      <PTM_Type>N6-acetyllysine</PTM_Type>
    </PTM>
    <PTM>
      <Position>65</Position>
      <PTM_Type>Phosphothreonine</PTM_Type>
    </PTM>
    <PTM>
      <Position>204</Position>
      <PTM_Type>Phosphotyrosine</PTM_Type>
    </PTM>
    <PTM>
      <Position>46</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
    <PTM>
      <Position>312</Position>
      <PTM_Type>N6-malonyllysine</PTM_Type>
    </PTM>
    <PTM>
      <Position>108</Position>
      <PTM_Type>N6-acetyllysine</PTM_Type>
    </PTM>
    <PTM>
      <Position>241</Position>
      <PTM_Type>Phosphothreonine</PTM_Type>
    </PTM>
    <PTM>
      <Position>39</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
    <PTM>
      <Position>37</Position>
      <PTM_Type>Phosphothreonine</PTM_Type>
    </PTM>
    <PTM>
      <Position>3</Position>
      <PTM_Type>Phosphotyrosine</PTM_Type>
    </PTM>
    <PTM>
      <Position>13</Position>
      <PTM_Type>N6-acetyllysine</PTM_Type>
    </PTM>
    <PTM>
      <Position>235</Position>
      <PTM_Type>Phosphothreonine</PTM_Type>
    </PTM>
  </PTM_List>
  <Molecule_Seq>
    <Protein_Seq>MPYQYPALTPEQKKELSDIAHRIVAPGKGILAADESTGSIAKRLQSIGTENTEENRRFYRQLLLTADDRVNPCIGGVILFHETLYQKADDGRPFPQVIKSKGGVVGIKVDKGVVPLAGTNGETTTQGLDGLSERCAQYKKDGADFAKWRCVLKIGEHTPSALAIMENANVLARYASICQQNGIVPIVEPEILPDGDHDLKRCQYVTEKVLAAVYKALSDHHIYLEGTLLKPNMVTPGHACTQKFSHEEIAMATVTALRRTVPPAVTGITFLSGGQSEEEASINLNAINKCPLLKPWALTFSYGRALQASALKAWGGKKENLKAAQEEYVKRALANSLACQGKYTPSGQAGAAASESLFVSNHAY</Protein_Seq>
    <DNA_Seq>AGTACCGGGTACGCAGGGGTGCCTCAACCACACTCCGTCCACGGACTCTCCGTTATTTTAGGAGGTCCCTGGCCAAAGATTTATTTCTCTTGACAACCAAGGGCCTCCGTCTGGATTTCCAAGGAAGAATTTCCTCTGAAGCACCGGAACTTGCTACTACCAGCACCATGCCCTACCAATATCCAGCACTGACCCCGGAGCAGAAGAAGGAGCTGTCTGACATCGCTCACCGCATCGTGGCACCTGGCAAGGGCATCCTGGCTGCAGATGAGTCCACTGGGAGCATTGCCAAGCGGCTGCAGTCCATTGGCACCGAGAACACCGAGGAGAACCGGCGCTTCTACCGCCAGCTGCTGCTGACAGCTGACGACCGCGTGAACCCCTGCATTGGGGGTGTCATCCTCTTCCATGAGACACTCTACCAGAAGGCGGATGATGGGCGTCCCTTCCCCCAAGTTATCAAATCCAAGGGCGGTGTTGTGGGCATCAAGGTAGACAAGGGCGTGGTCCCCCTGGCAGGGACAAATGGCGAGACTACCACCCAAGGGTTGGATGGGCTGTCTGAGCGCTGTGCCCAGTACAAGAAGGACGGAGCTGACTTCGCCAAGTGGCGTTGTGTGCTGAAGATTGGGGAACACACCCCCTCAGCCCTCGCCATCATGGAAAATGCCAATGTTCTGGCCCGTTATGCCAGTATCTGCCAGCAGAATGGCATTGTGCCCATCGTGGAGCCTGAGATCCTCCCTGATGGGGACCATGACTTGAAGCGCTGCCAGTATGTGACCGAGAAGGTGCTGGCTGCTGTCTACAAGGCTCTGAGTGACCACCACATCTACCTGGAAGGCACCTTGCTGAAGCCCAACATGGTCACCCCAGGCCATGCTTGCACTCAGAAGTTTTCTCATGAGGAGATTGCCATGGCGACCGTCACAGCGCTGCGCCGCACAGTGCCCCCCGCTGTCACTGGGATCACCTTCCTGTCTGGAGGCCAGAGTGAGGAGGAGGCGTCCATCAACCTCAATGCCATTAACAAGTGCCCCCTGCTGAAGCCCTGGGCCCTGACCTTCTCCTACGGCCGAGCCCTGCAGGCCTCTGCCCTGAAGGCCTGGGGCGGGAAGAAGGAGAACCTGAAGGCTGCGCAGGAGGAGTATGTCAAGCGAGCCCTGGCCAACAGCCTTGCCTGTCAAGGAAAGTACACTCCGAGCGGTCAGGCTGGGGCTGCTGCCAGCGAGTCCCTCTTCGTCTCTAACCACGCCTATTAAGCGGAGGTGTTCCCAGGCTGCCCCCAACAACTCCAGGCCCTGCCCCCTCCCACTCTTGAAGAGGAGGCCGCCTCCTCGGGGCTCCAGGCTGGCTTGCCCGCGCTCTTTCTTCCCTCGTGACAGTGGTGTGTGGTGTCGTCTGTGAATGCTAAGTCCATCACCCTTTCCGGCACACTGCCAAATAAACAGCTATTTAAGGGGG</DNA_Seq>
  </Molecule_Seq>
  <Tissuelocal_List>
    <TissueLocal>
      <TissueLocal>Skeletal muscle</TissueLocal>
    </TissueLocal>
  </Tissuelocal_List>
  <CellLocal_List>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Cytoplasm</CellLocal>
    </AsdMacromoleculeCelllocal>
  </CellLocal_List>
  <Gene>
    <Gene_Name>ALDOA</Gene_Name>
    <Gene_Alias>ALDA</Gene_Alias>
    <Gene_ID>226</Gene_ID>
    <Genbank_ACCN>NM_000034</Genbank_ACCN>
    <Protein_ACCN>NP_000025</Protein_ACCN>
    <HGNC_ID>414</HGNC_ID>
    <Gene_URL>http://www.ncbi.nlm.nih.gov/gene/226</Gene_URL>
    <UCSC_ID>uc002dvw.3</UCSC_ID>
    <EMBL_ID>ENSG00000149925</EMBL_ID>
  </Gene>
  <Disease_List>
    <Disease>
      <Disease_Name>Mycetoma</Disease_Name>
      <Disease_Detail>Mycetoma</Disease_Detail>
      <Disease_DB>MYC012</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/mycetoma?search=ALDOA#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Glycogen Storage Disease Type 12</Disease_Name>
      <Disease_Detail>Glycogen Storage Disease</Disease_Detail>
      <Disease_DB>GLY025</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/glycogen_storage_disease_type_12?search=ALDOA#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Eumycotic Mycetoma</Disease_Name>
      <Disease_Detail>Eumycotic Mycetoma</Disease_Detail>
      <Disease_DB>EMY001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/eumycotic_mycetoma?search=ALDOA#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Melanoma-Associated Retinopathy</Disease_Name>
      <Disease_Detail>Melanoma</Disease_Detail>
      <Disease_DB>MLN046</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/melanoma_associated_retinopathy?search=ALDOA#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Glycogen Storage Disease Xii</Disease_Name>
      <Disease_Detail>Glycogen Storage Disease</Disease_Detail>
      <Disease_DB>GLY043</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/glycogen_storage_disease_xii?search=ALDOA#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Lung Cancer</Disease_Name>
      <Disease_Detail>Lung Cancer</Disease_Detail>
      <Disease_DB>LNG032</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/lung_cancer?search=ALDOA#related_genes</Disease_URL>
    </Disease>
  </Disease_List>
  <PDB_List>
    <PDB>
      <PDB_Title>HUMAN MUSCLE ALDOLASE</PDB_Title>
      <PDB_ID>2ALD</PDB_ID>
      <Resolution>2.1</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2ALD</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystal structure of human muscle aldolase complexed with fructose 1,6-bisphosphate: mechanistic implications.</PubMed_Title>
      <Author>Dalby A, et al.</Author>
      <Journal>Protein Sci.1999 Feb;8(2):291-7.</Journal>
      <PubMed_ID>10048322</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>HUMAN MUSCLE FRUCTOSE 1,6-BISPHOSPHATE ALDOLASE COMPLEXED WITH FRUCTOSE 1,6-BISPHOSPHATE</PDB_Title>
      <PDB_ID>4ALD</PDB_ID>
      <Resolution>2.8</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4ALD</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>1,6-FRUCTOSE DIPHOSPHATE</Ligand_Name>
      <PubMed_Title>Crystal structure of human muscle aldolase complexed with fructose 1,6-bisphosphate: mechanistic implications.</PubMed_Title>
      <Author>Dalby A, et al.</Author>
      <Journal>Protein Sci.1999 Feb;8(2):291-7.</Journal>
      <PubMed_ID>10048322</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>ACTIVITY AND SPECIFICITY OF HUMAN ALDOLASES</PDB_Title>
      <PDB_ID>1ALD</PDB_ID>
      <Resolution>2.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1ALD</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Activity and specificity of human aldolases.</PubMed_Title>
      <Author>Gamblin SJ, et al.</Author>
      <Journal>J Mol Biol.1991 Jun 20;219(4):573-6.</Journal>
      <PubMed_ID>2056525</PubMed_ID>
    </PDB>
  </PDB_List>
  <Network_List>
    <Network>
      <Pathway_ID>ko00051</Pathway_ID>
      <Pathway_Title>Fructose and mannose metabolism</Pathway_Title>
      <Pathway_Class>Metabolism</Pathway_Class>
      <Pathway_Subclass>Carbohydrate metabolism</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko00010</Pathway_ID>
      <Pathway_Title>Glycolysis / Gluconeogenesis</Pathway_Title>
      <Pathway_Class>Metabolism</Pathway_Class>
      <Pathway_Subclass>Carbohydrate metabolism</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko01230</Pathway_ID>
      <Pathway_Title>Biosynthesis of amino acids</Pathway_Title>
      <Pathway_Class>Metabolism</Pathway_Class>
      <Pathway_Subclass>Overview</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko01200</Pathway_ID>
      <Pathway_Title>Carbon metabolism</Pathway_Title>
      <Pathway_Class>Metabolism</Pathway_Class>
      <Pathway_Subclass>Overview</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko01200</Pathway_ID>
      <Pathway_Title>Carbon metabolism</Pathway_Title>
      <Pathway_Class>Metabolism</Pathway_Class>
      <Pathway_Subclass>Overview</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko00680</Pathway_ID>
      <Pathway_Title>Methane metabolism</Pathway_Title>
      <Pathway_Class>Metabolism</Pathway_Class>
      <Pathway_Subclass>Energy metabolism</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko00030</Pathway_ID>
      <Pathway_Title>Pentose phosphate pathway</Pathway_Title>
      <Pathway_Class>Metabolism</Pathway_Class>
      <Pathway_Subclass>Carbohydrate metabolism</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko01200</Pathway_ID>
      <Pathway_Title>Carbon metabolism</Pathway_Title>
      <Pathway_Class>Metabolism</Pathway_Class>
      <Pathway_Subclass>Overview</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko00710</Pathway_ID>
      <Pathway_Title>Carbon fixation in photosynthetic organisms</Pathway_Title>
      <Pathway_Class>Metabolism</Pathway_Class>
      <Pathway_Subclass>Energy metabolism</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko00710</Pathway_ID>
      <Pathway_Title>Carbon fixation in photosynthetic organisms</Pathway_Title>
      <Pathway_Class>Metabolism</Pathway_Class>
      <Pathway_Subclass>Energy metabolism</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko00051</Pathway_ID>
      <Pathway_Title>Fructose and mannose metabolism</Pathway_Title>
      <Pathway_Class>Metabolism</Pathway_Class>
      <Pathway_Subclass>Carbohydrate metabolism</Pathway_Subclass>
    </Network>
  </Network_List>
  <Fold>
    <SCOP_Class>Alpha and beta proteins (a/b)</SCOP_Class>
    <SCOP_URL>http://scop.mrc-lmb.cam.ac.uk/scop/data/scop.b.d.b.bb.b.be.html</SCOP_URL>
    <CATH_Class>Mixed alpha-beta</CATH_Class>
    <CATH_URL>http://www.cathdb.info/pdb/1ald</CATH_URL>
  </Fold>
  <AllostericSite_List>
    <AllostericSite>
      <Site_Detail>site,73,Cys</Site_Detail>
      <Site_Reference>Sygusch J, et al. Biochem.J. 1997,327 ( Pt 3):717-720.</Site_Reference>
      <Site_Type>Unknown</Site_Type>
      <PubMed_ID>9581547</PubMed_ID>
    </AllostericSite>
  </AllostericSite_List>
  <Enzyme_Nomenclature_List>
    <Enzyme_Nomenclature>
      <Enzyme_DB_ID>4.1.2.13</Enzyme_DB_ID>
      <Enzyme_DB_URL>http://www.chem.qmul.ac.uk/iubmb/enzyme/EC4/1/2/13.html</Enzyme_DB_URL>
    </Enzyme_Nomenclature>
  </Enzyme_Nomenclature_List>
  <Modulator_List>
    <Modulator>
      <ASD_ID>ASD00030001</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00150001</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00870006</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01130001</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01130005</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
  </Modulator_List>
  <Create_Date>2012-05-31</Create_Date>
</Organism_Record>